.css-1xsl8rf{width:100%;display:-webkit-box;display:-webkit-flex;display:-ms-flexbox;display:flex;-webkit-align-items:center;-webkit-box-align:center;-ms-flex-align:center;align-items:center;position:relative;overflow:hidden;background:var(--alert-bg);-webkit-padding-start:var(--chakra-space-4);padding-inline-start:var(--chakra-space-4);-webkit-padding-end:var(--chakra-space-4);padding-inline-end:var(--chakra-space-4);padding-top:var(--chakra-space-1);padding-bottom:var(--chakra-space-1);--alert-fg:var(--chakra-colors-orange-600);--alert-bg:var(--chakra-colors-orange-100);font-weight:var(--chakra-fontWeights-semibold);padding-left:var(--chakra-space-4);}.chakra-ui-dark .css-1xsl8rf:not([data-theme]),[data-theme=dark] .css-1xsl8rf:not([data-theme]),.css-1xsl8rf[data-theme=dark]{--alert-fg:var(--chakra-colors-orange-200);--alert-bg:rgba(251, 211, 141, 0.16);}@media screen and (min-width: 48em){.css-1xsl8rf{padding-left:var(--chakra-space-8);}}Bitte aktivieren Sie Javascript um alle Funktionen nutzen zu können und ihre Nutzererfahrung zu verbessern.

Plenary session

PS 5
PS 5 | Trial designs that lead to medication availability in Europe

Termin

Datum: 09.12.2023

Zeit: 08:30 – 09:30

Ort / Stream:

Plenary hall

Chair

Programm

Plenary lecture
Is a comparison of new substances to placebo sufficient?
Hans-Christoph Diener (Essen, DE)
Plenary lecture
How to bring new migraine drugs to patients in Europe
Michel D. Ferrari (Leiden, NL)
Plenary lecture
New ideas for trials in cluster headache
Peter J. Goadsby (London, GB)

PS 5PS 5 | Trial designs that lead to medication availability in Europe

Termin

Chair

Programm

PS 5
PS 5 | Trial designs that lead to medication availability in Europe